What's new in PrEP research and advocacy? Click on the links below!
--
AVAC
August 2008
Anticipating the Results of PrEP Trials, calls for increased action from governments,
global health institutions, donors, researchers, and advocates to prepare for initial results – expected
as early as 2009 – from the first trials of antiretroviral drugs being tested for HIV prevention, known
as PrEP or pre-exposure prophylaxis. The report also provides the most up-to-date information
about ongoing and planned PrEP research, and lays out an agenda for action on key issues that must
be addressed as research on this promising HIV prevention intervention moves forward... click here to read more
Institute of Medicine (IOM)
21 February 2008
In 2007, the IOM convened a meeting to discuss how to improve the methodology, design, and conduct of HIV prevention trials, focusing on microbicide and pre-exposure prophylaxis (PrEP) trials, in order to increase their likelihood of success and to enable donors to optimally invest resources. This is a report of that meeting and discusses various ways to improve the design, monitoring, and analysis of late-stage randomized clinical trials of biomedical interventions to prevent HIV infection....click here to read more
PLoS Medicine
5 February 2008
This Perspectives piece discusses the new study published in PLoS Medicine, "Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir."
click here to read
**Kaiser Network PrEP Newsfeed**
|
